Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

BACKGROUND: Synovial sarcoma is a high-grade malignant tumor of soft tissue, characterized by the specific chromosomal translocation t(X;18), and its resultant SYT-SSX fusion gene. Despite intensive multimodality therapy, the majority of metastatic or relapsed diseases still remain incurable, thus s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Satoshi, Wada, Takuro, Ida, Kazunori, Sato, Yuriko, Nagoya, Satoshi, Tsukahara, Tomohide, Kimura, Sigeharu, Sahara, Hiroeki, Ikeda, Hideyuki, Shimozawa, Kumiko, Asanuma, Hiroko, Torigoe, Toshihiko, Hiraga, Hiroaki, Ishii, Takeshi, Tatezaki, Shin-ichiro, Sato, Noriyuki, Yamashita, Toshihiko
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545052/
https://www.ncbi.nlm.nih.gov/pubmed/15647119
http://dx.doi.org/10.1186/1479-5876-3-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545052/
https://www.ncbi.nlm.nih.gov/pubmed/15647119
http://dx.doi.org/10.1186/1479-5876-3-1

Ejemplares similares